Vladimir S Spiegelman

13PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersCancer geneticsImmunogenetics (incl. genetic immunology)Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 17, 2026
In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.

|May 13, 2026
Establishment of Patient-Derived Organoids for Pediatric Cancer Research.

|Jan 10, 2026
RNA-Binding Proteins: Modulators of Canonical Wnt Signaling Pathway.

Michael S Czap, Vikash Singh, Vladimir S Spiegelman

|Dec 02, 2025
IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy.

Mayura R Dhamdhere, Chethana P Gowda, Yuka Imamura

|Jul 08, 2025
AVJ16 inhibits lung carcinoma by targeting IGF2BP1.

Nadav Wallis, Tehila Gershon, Sojod Shaaby

|Jun 24, 2025
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Yali Ding, Bing He, Daniel Bogush

Pageof 3

Frequent Collaborators

2 joint publications

Irina A Elcheva

2 joint publications

Mayura R Dhamdhere

2 joint publications

Vikash Singh

2 joint publications

Serge Y Fuchs